Insights

18.04.23

By By Dr. Paula Vaccarello and Dr. Jörg Schneider

With more innovator companies targeting cell and gene therapy, it’s not surprising that investigational new

4.04.23

By Cori Gorman, Ph.D.

Successfully bringing cell and gene therapies through the regulatory process requires preparation and knowing what

28.03.23

By Cori Gorman, Ph.D.

The fields of cell and gene therapy are enormously promising while at the same time

22.03.23

By Dr. Jörg Schneider

Dr. Jörg Schneider, Director – Principal Consultant at BioPharma Excellence, shares key takeaways from Advanced

1.02.23

By Sebastian Teitz, Ph.D

More than 25 years after adopting the first version of the guideline on the viral

16.01.23

Regulators are becoming more open to alternative data sources in the context of rare disease

2 3 Next